IT seems that Guyanese are not taking seriously enough the tremendous impact that overweight has on the two main non-communicable diseases (NCDs)primarily responsible for deaths in this country – ...

The full spectrum of metabolic disorders, typically seen in older adults, is increasingly affecting children in India, and this includes being overweight or obese ...

Hims & Hers Health shares jumped sharply on Monday following reports that Novo Nordisk may distribute its obesity drugs to HIMS through t ...

Childhood obesity is a growing health concern worldwide, affecting millions of children every year. It occurs when a child’s weight is higher than what is healthy for their age and height. Excess ...

Cardiology groups say adults as young as 30 should assess cholesterol risk and consider treatment to prevent heart attacks ...

Eli Lilly (LLY) rated Sell/Avoid: overvaluation, slowing GLP-1 growth, Novo competition, bearish technicals and insider ...

Shares of Hims & Hers Health climbed about 5% on Thursday morning after the telehealth company said it entered a collaboration with Novo ...

Twenty percent of potentially eligible youth are prescribed GLP-1 RAs, with the odds of prescription higher with increasing age and BMI.

Aetna has agreed to pay $117.7 million to settle allegations that it submitted false or inaccurate diagnoses to juice Medicare Advantage payments. | Aetna has agreed to pay $117.7 million to settle ...

The AHA urges doctors to begin screening and treating patients who are still in their 30s, well before the risks of a heart attack and stroke are higher.

Eli Lilly LLY, a dominant player in the global obesity market, derives most of its revenues from its blockbuster GLP-1 medicines, Mounjaro for type II diabetes (T2D) and Zepbound for obesity. Despite ...

A new analysis of Medicare data shows mental health specialists who embraced telehealth did not see substantially more rural ...